Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 754 Records) |
Query Trace: Carcinoma and Egfr[original query] |
---|
Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery. Cancers 2023 9 15 (17): . Hyunjong Lee, Yoon-La Choi, Hong Kwan Kim, Yong Soo Choi, Hojoong Kim, Myung-Ju Ahn, Hong Ryul Pyo, Joon Young Ch |
A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety. Biomedicines 2023 9 11 (9): . Tatsuro Fukuhara, Kazuhiro Imai, Taku Nakagawa, Ryotaro Igusa, Hayato Yokota, Kana Watanabe, Aya Suzuki, Mami Morita, Ren Onodera, Akira Inoue, Masatomo Miura, Yoshihiro Minamiya, Makoto Maemon |
Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas. Human pathology 2023 9 . Haiyue Wang, Linghua Yan, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Dongmei L |
The Association of Epidermal Growth Factor Variant with Oral Squamous Cell Carcinoma. Environmental and molecular mutagenesis 2023 9 . Baris Ertugrul, Amal Mohammad, Goksu Kasarci, Sinem Bireller, Murat Ulusan, Bedia Cakmakog |
Association of PD-L1 tumor proportion score ?20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC. Cancer medicine 2023 8 . Yusuke Hamakawa, Yoko Agemi, Aya Shiba, Toshiki Ikeda, Yuko Higashi, Masaharu Aga, Kazuhito Miyazaki, Yuri Taniguchi, Yuki Misumi, Yukiko Nakamura, Tsuneo Shimokawa, Yusuke Saigusa, Nobuaki Kobayashi, Hiroaki Okamoto, Takeshi Kane |
Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M-positive: Case report and literature review. Thoracic cancer 2023 8 . Chihiro Maeda, Kanako Shinada, Shuji Murakami, Haruhiro Sai |
Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report. Cancer management and research 2023 8 15 803-808. Diming Wang, Wei Ye, Dongmei Chen, Qingming Shi, Dongchun |
Real-world challenges in undertaking NTRK fusion testing in non-small cell lung cancer. Journal of thoracic disease 2023 8 15 (7): 3811-3817. Ashleigh Poh, Abdelaziz Sammour, Jared Mathai, Joanne Peverall, Chris Van Vliet, Khashayar Asadi, Sagun Para |
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes. Molecular cancer 2023 7 22 (1): 120. Lorraine Dalens, Julie Niogret, Corentin Richard, Sandy Chevrier, Pascal Foucher, Bruno Coudert, Aurélie Lagrange, Laure Favier, Virginie Westeel, Stefano Kim, Olivier Adotevi, Caroline Chapusot, Laurent Martin, Laurent Arnould, Courèche-Guillaume Kaderbhai, Romain Boid |
Gene mutation profiling and clinical significances in patients with renal cell carcinoma. Clinics (Sao Paulo, Brazil) 2023 7 78 100259. Yongquan Wang, Peng He, Xiaozhou Zhou, Cong Wang, Jian Fu, Dawei Zhang, Deyang Liao, Zhansong Zhou, Chunman Wu, Wei Go |
Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients. Oral oncology 2023 7 144 106466. Sehui Kim, Chung Lee, Hyangmi Kim, Sun Och Yo |
Genetic Polymorphisms of ACE1 Rs4646994 Associated with Lung Cancer in Patients with Pulmonary Nodules: A Case-Control Study. Biomedicines 2023 6 11 (6): . Rong Qiao, Siyao Sang, Jiajun Teng, Hua Zhong, Hui Li, Baohui H |
Association Between 18F-Fluorodeoxyglucose Uptake and Mutation Status of Epidermal Growth Factor Receptor in Sinonasal Tract Cancer. Anticancer research 2023 6 43 (7): 3247-3253. Hidenori Suzuki, Eiichi Sasaki, Tsuneo Tamaki, Takeshi Kodaira, Masami Nishio, Daisuke Nishikawa, Shintaro Beppu, Hoshino Terada, Michi Sawabe, Nobuhiro Han |
Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection. Cancers 2023 12 15 (23): . Hwa Kyung Park, Yoo Duk Choi, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Joon Young Yoon, Chang-Seok Yoon, Hyung-Joo Oh, Young-Chul Kim, In-Jae |
Clonality Analysis for the Relationship between the Pulmonary Combined Neuroendocrine Carcinoma and "the So-Called Reported Histologic Transformation". Cancers 2023 12 15 (23): . Haiyue Wang, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Weijing Cai, Dongmei L |
Predictive Value of EGFR Mutation Status for First-Line Tyrosine Kinase Inhibitor Treatment in Patients with Advanced Lung Cancer. Alternative therapies in health and medicine 2023 12 . Youqin Xie, Jinliang Chen, Wen Zhu, Zhihui Ye, Xuedong |
Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 12 187 107439. Lei Wang, Meng Diao, Zheng Zhang, Minlin Jiang, Shifu Chen, Deping Zhao, Zhenguo Liu, Caicun Zh |
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer. JAMA network open 2023 12 6 (12): e2347700. Tomohiro Sakamoto, Taichi Matsubara, Takayuki Takahama, Toshihide Yokoyama, Atsushi Nakamura, Takaaki Tokito, Tatsuro Okamoto, Hiroaki Akamatsu, Masahide Oki, Yuki Sato, Kazunori Tobino, Satoshi Ikeda, Masahide Mori, Chihiro Mimura, Ken Maeno, Satoru Miura, Toshiyuki Harada, Kunihiro Nishimura, Manabu Hiraoka, Hirotsugu Kenmotsu, Junya Fujimoto, Mototsugu Shimokawa, Nobuyuki Yamamoto, Kazuhiko Nakaga |
Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
Aumolertinib: effective treatment for asymptomatic pulmonary giant cell carcinoma with EGFR L858R mutation - a case report. Frontiers in oncology 2023 12 13 1279045. Wenxing Yang, Ze Yang, Kaiqiang Wang, Peiquan Zhu, Jiangtao |
PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients. Diagnostic pathology 2023 11 18 (1): 119. Weiguang Gu, Wenya Zhuang, Mengxia Zhuang, Minhong He, Zhihua |
Molecular study of colorectal carcinoma and EGFR gene mutations. Cellular and molecular biology (Noisy-le-Grand, France) 2023 10 69 (9): 177-182. Shayan Rasheed Abubakir, Hazha Jamal Hiday |
Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non-Small Cell Lung Cancer. Clinical Medicine Insights. Oncology 2023 10 17 11795549231184918. Lihuan Zhu, Dongsheng Zhou, Yiyong Chen, Tianxing Guo, Wenshu Chen, Xiaojie P |
Case report: Efficacy of icotinib treatment in lung adenocarcinoma with esophageal squamous cell carcinoma: a rare case of double primary malignant tumors. Frontiers in medicine 2024 4 11 1266062. Min Deng, Xiaoqing Li, Honghao Mu, Man Wei, Lan S |
Expression of Epidermal Growth Factor Receptor (EGFR) and ?-catenin in Colorectal Carcinoma and its Correlation with Tumor Grade and Stage. Indian journal of surgical oncology 2024 1 14 (4): 758-764. Alka Yadav, Sompal Singh, Namrata Sarin, Mukta Pujani, Ruchira Wadhwa, Monica Sarohi, Aiswarya |
A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma. Journal of translational medicine 2024 1 22 (1): 87. Jie Peng, Dan Zou, Xudong Zhang, Honglian Ma, Lijie Han, Biao Y |
FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma. Contemporary oncology (Poznan, Poland) 2024 1 27 (3): 211-216. Julia Pikul, Anna Rzepakowska, Marcin Machnicki, Tomasz Stok?o |
Discovery of genomic and transcriptomic pleiotropy between kidney function and soluble receptor for advanced glycation end-products using correlated meta-analyses: The Long Life Family Study (LLFS). medRxiv : the preprint server for health sciences 2024 1 . Mary F Feitosa, Shiow J Lin, Sandeep Acharya, Bharat Thyagarajan, Mary K Wojczynski, Allison L Kuipers, Alexander Kulminski, Kaare Christensen, Joseph M Zmuda, Michael R Brent, Michael A Provin |
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma". Thoracic cancer 2024 1 . Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, Tetsuya Isaka, Kanako Shinada, Emi Yoshioka, Atsuya Narita, Kengo Katakura, Tetsuro Kondo, Terufumi Kato, Takuya Nagashima, Haruhiro Saito, Hiroyuki I |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: